Kenvue Unit Can't Nix BIPA Suit Over Neutrogena Skin360 App
A Kenvue unit can't escape a proposed class action alleging it unlawfully stores facial scans of people who use its Neutrogena Skin360 tool in violation of Illinois' biometric privacy statute, after a New Jersey federal judge said those users are not "patient[s] in a healthcare setting" under the statute's healthcare exemption.
Walgreens' $24B Take-Private Deal Moves It Out Of Spotlight
Walgreens' $23.7 billion deal with private equity firm Sycamore Partners will take the pharmacy retailer off the public market and ultimately out of the spotlight as it looks to quietly continue in its turnaround efforts.
HHS Comment Reversal Sets Stage For Quick Policy Changes
The sudden reversal at the U.S. Department of Health and Human Services of a longstanding commitment to robust public engagement clears the way for fast-paced changes to Medicaid and other massive programs, putting more pressure on compliance officers and sending more lobbying work behind closed doors.
Kenvue Unit Can't Nix BIPA Suit Over Neutrogena Skin360 App
A Kenvue unit can't escape a proposed class action alleging it unlawfully stores facial scans of people who use its Neutrogena Skin360 tool in violation of Illinois' biometric privacy statute, after a New Jersey federal judge said those users are not "patient[s] in a healthcare setting" under the statute's healthcare exemption.
Walgreens' $24B Take-Private Deal Moves It Out Of Spotlight
Walgreens' $23.7 billion deal with private equity firm Sycamore Partners will take the pharmacy retailer off the public market and ultimately out of the spotlight as it looks to quietly continue in its turnaround efforts.
HHS Comment Reversal Sets Stage For Quick Policy Changes
The sudden reversal at the U.S. Department of Health and Human Services of a longstanding commitment to robust public engagement clears the way for fast-paced changes to Medicaid and other massive programs, putting more pressure on compliance officers and sending more lobbying work behind closed doors.
Expert Analysis
Attorneys at Hooper Lundy discuss a number of new California laws that raise pressing issues for independent physi... (more story)
Two recently resolved cases involving pharmaceutical manufacturers may make it more difficult for False Claims Act... (more story)
.png)
An Iowa federal court erred in its recent decision in Goldfinch Laboratory v. Iowa Pathology Associates by focusin... (more story)
Deals & Corporate Governance More
A Washington federal judge has trimmed Eli Lilly's lawsuit against two Seattle-area clinics and the doctors who run them for allegedly duping consumers into buying copycat versions of its diabetes and weight l... (more story)
The first cohort of biotech initial public offerings this year is out the door and off to what experts say is an "OK" start that could get better as long as the right pieces come together for the space.
The founder of Masimo Corp. has urged a New York federal court to permanently toss the medical technology company's suit alleging he manipulated a shareholder vote, arguing that the suit fails to state a plaus... (more story)
The U.S. Department of Justice wants to be there when orthodontists and consumers who purchased clear teeth aligners face off with the company behind Invisalign at the Ninth Circuit next month, so it can tell ... (more story)
In this week's Taxation With Representation, Walgreens Boots Alliance goes private via a deal with Sycamore Partners, Honeywell buys Sundyne from Warburg Pincus, and Jazz Pharmaceuticals acquires Chimerix.
The Federal Trade Commission moved Thursday to block private equity firm GTCR BC Holdings LLC's planned $627 million acquisition of Surmodics Inc. over concerns about competition for medical device coatings.
Digital Health & Technology More
A Court of Federal Claims judge has rejected a protest over a $256.8 million U.S. Department of Veterans Affairs telehealth program support contract, saying the protester hadn't shown the VA "pre-selected" the... (more story)
Following campaign-season promises about banning drug advertising on television, the pharmaceutical industry is closely watching for signs of tighter enforcement. Food and drug attorneys caution against overlo... (more story)
Artificial intelligence-focused physical therapy startup Hinge Health Inc. on Monday filed plans for an initial public offering, represented by Latham & Watkins LLP and underwriters counsel Davis Polk & Wardwe... (more story)
The U.S. Government Accountability Office has sustained a protest over a $19.9 million National Institutes of Health software development task order, finding the NIH unreasonably treated similar aspects of the... (more story)
A Texas federal judge has refused to issue an injunction that would allow compounding pharmacies to produce a lucrative weight loss drug, ruling that the U.S. Food and Drug Administration was within its author... (more story)
A Florida federal judge has refused to release Orlando Health Inc. from a proposed class action accusing it of unlawfully sharing patients' private information with Meta Platforms and Google through ad trackin... (more story)
Policy & Compliance More
The Federal Trade Commission initiated its first merger challenge since the start of President Donald Trump's current term, arguing that a private equity firm's plans to buy a medical device company would lead... (more story)
A North Carolina federal judge has found that Merck did not violate state law by not including warnings about its Human Papillomavirus vaccine Gardasil, saying there was a "paucity" of evidence that the vaccin... (more story)
The U.S. Supreme Court is set to hear a First Amendment challenge to a Colorado ban on mental health professionals using "conversion" therapy intended to help change minors' gender identity or sexual orientation.
Zydus Pharmaceuticals Inc. has reached a deal in principle with states and Native American tribes that should quash claims related to the company's alleged role in exasperating the opioid crisis.
Hundreds of American hospitals are "on the brink of collapse" and letting MultiPlan and a host of insurers who have been accused of conspiring to underpay out-of-network providers off the hook will not improve... (more story)
An Alaska federal judge has allowed most of the state's Racketeer Influenced and Corrupt Organization Act claims to move forward against pharmacy benefits manager Express Scripts for its alleged role in the opioid epidemic.